Revance and Crown are almost ready to close their deal after earlier bidding war
The fight over who gets control of Revance Therapeutics and its Botox competitor, Daxxify, is coming to a close.
On Wednesday, Revance said it’s moving …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
